Skip to main content
NCBI home page
Biochemical Journal logoLink to Biochemical Journal
. 2001 Aug 1;357(Pt 3):811–818. doi: 10.1042/0264-6021:3570811

Increase in class 2 aldehyde dehydrogenase expression by arachidonic acid in rat hepatoma cells.

R A Canuto 1, M Ferro 1, R A Salvo 1, A M Bassi 1, A Trombetta 1, M Maggiora 1, G Martinasso 1, R Lindahl 1, G Muzio 1
PMCID: PMC1222011  PMID: 11463352

Abstract

Aldehyde dehydrogenase (ALDH) is a family of several isoenzymes important in cell defence against both exogenous and endogenous aldehydes. Compared with normal hepatocytes, in rat hepatoma cells the following changes in the expression of ALDH occur: cytosolic class 3 ALDH expression appears and mitochondrial class 2 ALDH decreases. In parallel with these changes, a decrease in the polyunsaturated fatty acid content in membrane phospholipids occurs. In the present study we demonstrated that restoring the levels of arachidonic acid in 7777 and JM2 rat hepatoma cell lines to those seen in hepatocytes decreases hepatoma cell growth, and increases class 2 ALDH activity. This latter effect appears to be due to an increased gene transcription of class 2 ALDH. To account for this increase, we examined whether peroxisome-proliferator-activated receptors (PPARs) or lipid peroxidation were involved. We demonstrated a stimulation of PPAR expression, which is different in the two hepatoma cell lines: in the 7777 cell line, there was an increase in PPAR alpha expression, whereas PPAR gamma expression increased in JM2 cells. We also found increased lipid peroxidation, but this increase became evident at a later stage when class 2 ALDH expression had already increased. In conclusion, arachidonic acid added to the culture medium of hepatoma cell lines is able to partially restore the normal phenotype of class 2 ALDH, in addition to a decrease in cell growth.

Full Text

The Full Text of this article is available as a PDF (228.5 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barrera G., Muraca R., Pizzimenti S., Serra A., Rosso C., Saglio G., Farace M. G., Fazio V. M., Dianzani M. U. Inhibition of c-myc expression induced by 4-hydroxynonenal, a product of lipid peroxidation, in the HL-60 human leukemic cell line. Biochem Biophys Res Commun. 1994 Aug 30;203(1):553–561. doi: 10.1006/bbrc.1994.2218. [DOI] [PubMed] [Google Scholar]
  2. Bunting K. D., Lindahl R., Townsend A. J. Oxazaphosphorine-specific resistance in human MCF-7 breast carcinoma cell lines expressing transfected rat class 3 aldehyde dehydrogenase. J Biol Chem. 1994 Sep 16;269(37):23197–23203. [PubMed] [Google Scholar]
  3. Bégin M. E., Ells G., Das U. N., Horrobin D. F. Differential killing of human carcinoma cells supplemented with n-3 and n-6 polyunsaturated fatty acids. J Natl Cancer Inst. 1986 Nov;77(5):1053–1062. [PubMed] [Google Scholar]
  4. Bégin M. E., Sircar S., Weber J. M. Differential sensitivity of tumorigenic and genetically related non-tumorigenic cells to cytotoxic polyunsaturated fatty acids. Anticancer Res. 1989 Jul-Aug;9(4):1049–1052. [PubMed] [Google Scholar]
  5. Canuto R. A., Ferro M., Maggiora M., Federa R., Brossa O., Bassi A. M., Lindahl R., Muzio G. In hepatoma cell lines restored lipid peroxidation affects cell viability inversely to aldehyde metabolizing enzyme activity. Adv Exp Med Biol. 1997;414:113–122. doi: 10.1007/978-1-4615-5871-2_14. [DOI] [PubMed] [Google Scholar]
  6. Canuto R. A., Ferro M., Muzio G., Bassi A. M., Leonarduzzi G., Maggiora M., Adamo D., Poli G., Lindahl R. Role of aldehyde metabolizing enzymes in mediating effects of aldehyde products of lipid peroxidation in liver cells. Carcinogenesis. 1994 Jul;15(7):1359–1364. doi: 10.1093/carcin/15.7.1359. [DOI] [PubMed] [Google Scholar]
  7. Canuto R. A., Garcea R., Biocca M., Pascale R., Pirisi L., Feo F. The subcellular distribution and properties of aldehyde dehydrogenase of hepatoma AH-130. Eur J Cancer Clin Oncol. 1983 Mar;19(3):389–400. doi: 10.1016/0277-5379(83)90138-4. [DOI] [PubMed] [Google Scholar]
  8. Canuto R. A., Muzio G., Bassi A. M., Maggiora M., Leonarduzzi G., Lindahl R., Dianzani M. U., Ferro M. Enrichment with arachidonic acid increases the sensitivity of hepatoma cells to the cytotoxic effects of oxidative stress. Free Radic Biol Med. 1995 Feb;18(2):287–293. doi: 10.1016/0891-5849(94)e0137-8. [DOI] [PubMed] [Google Scholar]
  9. Canuto R. A., Muzio G., Biocca M. E., Dianzani M. U. Lipid peroxidation in rat AH-130 hepatoma cells enriched in vitro with arachidonic acid. Cancer Res. 1991 Sep 1;51(17):4603–4608. [PubMed] [Google Scholar]
  10. Canuto R. A., Muzio G., Biocca M. E., Dianzani M. U. Oxidative metabolism of 4-hydroxy-2,3-nonenal during diethyl-nitrosamine-induced carcinogenesis in rat liver. Cancer Lett. 1989 Jul 1;46(1):7–13. doi: 10.1016/0304-3835(89)90208-5. [DOI] [PubMed] [Google Scholar]
  11. Canuto R. A., Muzio G., Ferro M., Maggiora M., Federa R., Bassi A. M., Lindahl R., Dianzani M. U. Inhibition of class-3 aldehyde dehydrogenase and cell growth by restored lipid peroxidation in hepatoma cell lines. Free Radic Biol Med. 1999 Feb;26(3-4):333–340. doi: 10.1016/s0891-5849(98)00206-8. [DOI] [PubMed] [Google Scholar]
  12. Canuto R. A., Muzio G., Maggiora M., Poli G., Biasi F., Dianzani M. U., Ferro M., Bassi A. M., Penco S., Marinari U. M. Ability of different hepatoma cells to metabolize 4-hydroxynonenal. Cell Biochem Funct. 1993 Jun;11(2):79–86. doi: 10.1002/cbf.290110202. [DOI] [PubMed] [Google Scholar]
  13. Cao Q. N., Tu G. C., Weiner H. Mitochondria as the primary site of acetaldehyde metabolism in beef and pig liver slices. Alcohol Clin Exp Res. 1988 Oct;12(5):720–724. doi: 10.1111/j.1530-0277.1988.tb00271.x. [DOI] [PubMed] [Google Scholar]
  14. Chao Y. C., Wang M. F., Tang H. S., Hsu C. T., Yin S. J. Genotyping of alcohol dehydrogenase at the ADH2 and ADH3 loci by using a polymerase chain reaction and restriction-fragment-length polymorphism in Chinese alcoholic cirrhotics and non-alcoholics. Proc Natl Sci Counc Repub China B. 1994 Jul;18(3):101–106. [PubMed] [Google Scholar]
  15. Chen J. J., Yu B. P. Detoxification of reactive aldehydes in mitochondria: effects of age and dietary restriction. Aging (Milano) 1996 Oct;8(5):334–340. doi: 10.1007/BF03339590. [DOI] [PubMed] [Google Scholar]
  16. Chen Q., Galleano M., Cederbaum A. I. Cytotoxicity and apoptosis produced by arachidonic acid in Hep G2 cells overexpressing human cytochrome P4502E1. J Biol Chem. 1997 Jun 6;272(23):14532–14541. doi: 10.1074/jbc.272.23.14532. [DOI] [PubMed] [Google Scholar]
  17. Conney A. H., Lou Y. R., Xie J. G., Osawa T., Newmark H. L., Liu Y., Chang R. L., Huang M. T. Some perspectives on dietary inhibition of carcinogenesis: studies with curcumin and tea. Proc Soc Exp Biol Med. 1997 Nov;216(2):234–245. doi: 10.3181/00379727-216-44173. [DOI] [PubMed] [Google Scholar]
  18. Corton J. C., Anderson S. P., Stauber A. Central role of peroxisome proliferator-activated receptors in the actions of peroxisome proliferators. Annu Rev Pharmacol Toxicol. 2000;40:491–518. doi: 10.1146/annurev.pharmtox.40.1.491. [DOI] [PubMed] [Google Scholar]
  19. Das U. N., Prasad V. V., Reddy D. R. Local application of gamma-linolenic acid in the treatment of human gliomas. Cancer Lett. 1995 Aug 1;94(2):147–155. doi: 10.1016/0304-3835(95)03844-m. [DOI] [PubMed] [Google Scholar]
  20. Greenfield N. J., Pietruszko R. Two aldehyde dehydrogenases from human liver. Isolation via affinity chromatography and characterization of the isozymes. Biochim Biophys Acta. 1977 Jul 8;483(1):35–45. doi: 10.1016/0005-2744(77)90005-5. [DOI] [PubMed] [Google Scholar]
  21. Hartley D. P., Petersen D. R. Profiles of hepatic cellular protein adduction by malondialdehyde and 4-hydroxynonenal. Studies with isolated hepatocytes. Adv Exp Med Biol. 1997;414:123–131. doi: 10.1007/978-1-4615-5871-2_15. [DOI] [PubMed] [Google Scholar]
  22. Huang M., Lindahl R. Aldehyde dehydrogenase heterogeneity in rat hepatic cells. Arch Biochem Biophys. 1990 Mar;277(2):296–300. doi: 10.1016/0003-9861(90)90582-j. [DOI] [PubMed] [Google Scholar]
  23. Issemann I., Prince R. A., Tugwood J. D., Green S. The peroxisome proliferator-activated receptor:retinoid X receptor heterodimer is activated by fatty acids and fibrate hypolipidaemic drugs. J Mol Endocrinol. 1993 Aug;11(1):37–47. doi: 10.1677/jme.0.0110037. [DOI] [PubMed] [Google Scholar]
  24. Jiang W. G., Redfern A., Bryce R. P., Mansel R. E. Peroxisome proliferator activated receptor-gamma (PPAR-gamma) mediates the action of gamma linolenic acid in breast cancer cells. Prostaglandins Leukot Essent Fatty Acids. 2000 Feb;62(2):119–127. doi: 10.1054/plef.1999.0131. [DOI] [PubMed] [Google Scholar]
  25. Jump D. B., Thelen A., Mater M. Dietary polyunsaturated fatty acids and hepatic gene expression. Lipids. 1999;34 (Suppl):S209–S212. doi: 10.1007/BF02562292. [DOI] [PubMed] [Google Scholar]
  26. King G., Hirst L., Holmes R. Human corneal and lens aldehyde dehydrogenases. Localization and function(s) of ocular ALDH1 and ALDH3 isozymes. Adv Exp Med Biol. 1999;463:189–198. [PubMed] [Google Scholar]
  27. Leonarduzzi G., Scavazza A., Biasi F., Chiarpotto E., Camandola S., Vogel S., Dargel R., Poli G. The lipid peroxidation end product 4-hydroxy-2,3-nonenal up-regulates transforming growth factor beta1 expression in the macrophage lineage: a link between oxidative injury and fibrosclerosis. FASEB J. 1997 Sep;11(11):851–857. doi: 10.1096/fasebj.11.11.9285483. [DOI] [PubMed] [Google Scholar]
  28. Lindahl R. Aldehyde dehydrogenases and their role in carcinogenesis. Crit Rev Biochem Mol Biol. 1992;27(4-5):283–335. doi: 10.3109/10409239209082565. [DOI] [PubMed] [Google Scholar]
  29. Lindahl R., Petersen D. R. Lipid aldehyde oxidation as a physiological role for class 3 aldehyde dehydrogenases. Biochem Pharmacol. 1991 Jun 1;41(11):1583–1587. doi: 10.1016/0006-2952(91)90157-z. [DOI] [PubMed] [Google Scholar]
  30. Lindahl R. Subcellular distribution and properties of aldehyde dehydrogenase from 2-acetylaminofluorene-induced rat hepatomas. Biochem J. 1979 Oct 1;183(1):55–64. doi: 10.1042/bj1830055. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Luckey S. W., Tjalkens R. B., Petersen D. R. Mechanism of inhibition of rat liver class 2 ALDH by 4-hydroxynonenal. Adv Exp Med Biol. 1999;463:71–77. doi: 10.1007/978-1-4615-4735-8_9. [DOI] [PubMed] [Google Scholar]
  32. Pappas P., Stephanou P., Sotiropoulou M., Murphy C., Salminen L., Marselos M. Effects of tamoxifen and toremifene on ALDH1 and ALDH3 in human retinal pigment epithelial cells and rat liver. Adv Exp Med Biol. 1999;463:151–158. doi: 10.1007/978-1-4615-4735-8_18. [DOI] [PubMed] [Google Scholar]
  33. Parola M., Robino G., Marra F., Pinzani M., Bellomo G., Leonarduzzi G., Chiarugi P., Camandola S., Poli G., Waeg G. HNE interacts directly with JNK isoforms in human hepatic stellate cells. J Clin Invest. 1998 Dec 1;102(11):1942–1950. doi: 10.1172/JCI1413. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Pchelintseva O., Pak Y. K., Weiner H. Identification of protein-receptor components required for the import of prealdehyde dehydrogenase into rat liver mitochondria. Arch Biochem Biophys. 1995 Oct 20;323(1):54–62. doi: 10.1006/abbi.1995.0009. [DOI] [PubMed] [Google Scholar]
  35. Pinaire J., Chou W. Y., Stewart M., Dipple K., Crabb D. Activity of the human aldehyde dehydrogenase 2 promoter is influenced by the balance between activation by hepatocyte nuclear factor 4 and repression by perosixome proliferator activated receptor delta, chicken ovalbumin upstream promoter-transcription factor, and apolipoprotein regulatory protein-1. Adv Exp Med Biol. 1999;463:115–121. doi: 10.1007/978-1-4615-4735-8_14. [DOI] [PubMed] [Google Scholar]
  36. Spycher S., Tabataba-Vakili S., O'Donnell V. B., Palomba L., Azzi A. 4-hydroxy-2,3-trans-nonenal induces transcription and expression of aldose reductase. Biochem Biophys Res Commun. 1996 Sep 13;226(2):512–516. doi: 10.1006/bbrc.1996.1386. [DOI] [PubMed] [Google Scholar]
  37. Steinmetz C. G., Xie P., Weiner H., Hurley T. D. Structure of mitochondrial aldehyde dehydrogenase: the genetic component of ethanol aversion. Structure. 1997 May 15;5(5):701–711. doi: 10.1016/s0969-2126(97)00224-4. [DOI] [PubMed] [Google Scholar]
  38. Stewart M. J., Malek K., Crabb D. W. Distribution of messenger RNAs for aldehyde dehydrogenase 1, aldehyde dehydrogenase 2, and aldehyde dehydrogenase 5 in human tissues. J Investig Med. 1996 Feb;44(2):42–46. [PubMed] [Google Scholar]
  39. Takeda S., Horrobin D. F., Manku M., Sim P. G., Ells G., Simmons V. Lipid peroxidation in human breast cancer cells in response to gamma-linolenic acid and iron. Anticancer Res. 1992 Mar-Apr;12(2):329–333. [PubMed] [Google Scholar]
  40. Takeda S., Sim P. G., Horrobin D. F., Sanford T., Chisholm K. A., Simmons V. Mechanism of lipid peroxidation in cancer cells in response to gamma-linolenic acid (GLA) analyzed by GC-MS(I): Conjugated dienes with peroxyl (or hydroperoxyl) groups and cell-killing effects. Anticancer Res. 1993 Jan-Feb;13(1):193–199. [PubMed] [Google Scholar]
  41. Vasiliou V., Kozak C. A., Lindahl R., Nebert D. W. Mouse microsomal Class 3 aldehyde dehydrogenase: AHD3 cDNA sequence, inducibility by dioxin and clofibrate, and genetic mapping. DNA Cell Biol. 1996 Mar;15(3):235–245. doi: 10.1089/dna.1996.15.235. [DOI] [PubMed] [Google Scholar]
  42. Watabiki T., Tokiyasu T., Yoshida M., Okii Y., Yoshimura S., Akane A. Intralobular distribution of class I alcohol dehydrogenase and aldehyde dehydrogenase 2 activities in the hamster liver. Alcohol Clin Exp Res. 1999 Apr;23(4 Suppl):52S–55S. doi: 10.1111/j.1530-0277.1999.tb04534.x. [DOI] [PubMed] [Google Scholar]
  43. Wischusen S. M., Evces S., Lindahl R. Changes in aldehyde dehydrogenase activity during diethylnitrosamine- or 2-acetylaminofluorene-initiated rat hepatocarcinogenesis. Cancer Res. 1983 Apr;43(4):1710–1715. [PubMed] [Google Scholar]
  44. Yin S. J. Alcohol dehydrogenase: enzymology and metabolism. Alcohol Alcohol Suppl. 1994;2:113–119. [PubMed] [Google Scholar]
  45. Yoshida A., Ikawa M., Hsu L. C., Tani K. Molecular abnormality and cDNA cloning of human aldehyde dehydrogenases. Alcohol. 1985 Jan-Feb;2(1):103–106. doi: 10.1016/0741-8329(85)90024-2. [DOI] [PubMed] [Google Scholar]
  46. Yoshida A. Molecular genetics of human aldehyde dehydrogenase. Pharmacogenetics. 1992 Aug;2(4):139–147. doi: 10.1097/00008571-199208000-00001. [DOI] [PubMed] [Google Scholar]
  47. Zimatkin S. M., Liopo A. V., Deitrich R. A. Oxidation of ethanol to acetaldehyde in brain and the possible behavioral consequences. Adv Exp Med Biol. 1999;463:231–236. doi: 10.1007/978-1-4615-4735-8_28. [DOI] [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES